Mary O Omotoso
Overview
Explore the profile of Mary O Omotoso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Yao Z, Wang H, Ecker J, Omotoso M, Lee J, et al.
Sci Adv
. 2024 Dec;
10(50):eadm7928.
PMID: 39671478
Tissue-resident memory T (T) cells preferentially reside in peripheral tissues, serving as key players in tumor immunity and immunotherapy. The lack of effective approaches for expanding T cells and delivering...
2.
Omotoso M, Est-Witte S, Shannon S, Li S, Nair N, Neshat S, et al.
Biomaterials
. 2024 Sep;
313:122773.
PMID: 39217794
The development of artificial Antigen Presenting Cells (aAPCs) has led to improvements in adoptive T cell therapy (ACT), an immunotherapy, for cancer treatment. aAPCs help to streamline the consistent production...
3.
Omotoso M, Lanis M, Schneck J
Curr Protoc
. 2024 Feb;
4(2):e976.
PMID: 38400601
Antigen-presenting cells (APCs), such as dendritic cells and macrophages, have a unique ability to survey the body and present information to T cells via peptide-loaded major histocompatibility complexes (signal 1)....
4.
Livingston N, Hickey J, Sim H, Salathe S, Choy J, Kong J, et al.
Adv Mater
. 2024 Feb;
36(23):e2310043.
PMID: 38358310
T cells are critical mediators of antigen-specific immune responses and are common targets for immunotherapy. Biomaterial scaffolds have previously been used to stimulate antigen-presenting cells to elicit antigen-specific immune responses;...
5.
Est-Witte S, Livingston N, Omotoso M, Green J, Schneck J
Semin Immunol
. 2021 Dec;
56:101541.
PMID: 34922816
T cell therapy shows promise as an immunotherapy in both immunostimulatory and immunosuppressive applications. However, the forms of T cell-based therapy that are currently in the clinic, such as adoptive...